Jin Medical International Statistics
Total Valuation
ZJYL has a market cap or net worth of $605.84 million. The enterprise value is $592.35 million.
| Market Cap | 605.84M |
| Enterprise Value | 592.35M |
Important Dates
The next estimated earnings date is Friday, May 3, 2024, after market close.
| Earnings Date | May 3, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ZJYL has 156.55 million shares outstanding.
| Shares Outstanding | 156.55M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 75.84% |
| Owned by Institutions (%) | 0.11% |
| Float | 37.45M |
Valuation Ratios
The trailing PE ratio is 194.00.
| PE Ratio | 194.00 |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 25.66 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.89, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.89 |
| Quick Ratio | 3.00 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 258 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +938.17% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | +938.17% |
| 50-Day Moving Average | 5.60 |
| 200-Day Moving Average | 3.22 |
| Relative Strength Index (RSI) | 46.76 |
| Average Volume (30 Days) | 557,543 |
Short Selling Information
The latest short interest is 1.10 million, so 0.70% of the outstanding shares have been sold short.
| Short Interest | 1.10M |
| Short Previous Month | 1.22M |
| Short % of Shares Out | 0.70% |
| Short % of Float | 2.93% |
| Short Ratio (days to cover) | 1.87 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | n/a |
| Pretax Income | n/a |
| Net Income | n/a |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | $0.02 |
Balance Sheet
The company has $13.38 million in cash and $1.46 million in debt, giving a net cash position of $11.92 million or $0.08 per share.
| Cash & Cash Equivalents | 13.38M |
| Total Debt | 1.46M |
| Net Cash | 11.92M |
| Net Cash Per Share | $0.08 |
| Equity / Book Value | 23.55M |
| Book Value Per Share | 0.15 |
| Working Capital | 21.61M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ZJYL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.52% |
| Shareholder Yield | -18.52% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 8, 2024. It was a forward split with a ratio of 20:1.
| Last Split Date | Feb 8, 2024 |
| Split Type | Forward |
| Split Ratio | 20:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |